Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facility
Piramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectables demand, supporting its ADC manufacturing program.
Piramal Pharma Solutions draws $80 mn expansion plan for injectables facility in US
Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 2027.
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has unveiled an $80M investment plan to expand its Lexington,
Piramal Pharma Solutions Plans $80M Expansion for Kentucky Facility
As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.
Piramal Pharma to invest $80 million in expanding Kentucky's sterile injectables facility
The investment has been financed through bank loans and internal accruals, and aims to enhance site’s capacity to meet rising demand, said the company.
Piramal Pharma to invest $80 million in Kentucky facility expansion
Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.
Piramal Pharma Ahmedabad facility gets EIR from USFDA
Piramal Pharma’s stock price rose 2% in the opening trading on September 30 after the business received an Establishment Inspection Report (EIR) for its production facility in Ahmedabad, India. The USFDA examined the plant in July 2024 and issued a No Action Indicated (NAI) classification based on Zero Form – 483 observations.
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, Kentucky facility.
Lane Report10h
Piramal Pharma Solutions investing $80M to expand Lexington manufacturing, create 45 jobs
Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...
ET Now on MSN2h
Stocks in News, October 1: Tata Power, NTPC, India Glycols, Bank of Maharashtra, Piramal Pharma, Blue Dart
Gift Nifty is indicating a rebound in Sensex and Nifty after yesterday's fall. Around 7:20 AM, Gift traded firmly in the ...
Piramal Pharma shares gain 2% after EIR from USFDA for Ahmedabad facility
In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) ...
US Firms Reaching Out as Biosecure Act Closes in, Piramal Says
US drugmakers have begun reaching out to explore contract manufacturing possibilities to Piramal Pharma Ltd. as they gear up ...